Table 3.
Clinical evaluation score (CES) for discrimination between symptomatic and asymptomatic tumour patients.
Symptoms | Absent | Present | |
---|---|---|---|
Intermittent | Persistent | ||
Headaches | 0 | 1 | 2 |
Palpitations | 0 | 1 | 2 |
Sweating | 0 | 1 | 2 |
Tiredness | 0 | 0.5 | 1 |
Nausea | 0 | 0.5 | 1 |
Vertigo | 0 | 0.5 | 1 |
Psychea | 0 | 0.5 | 1 |
Weight loss | 0 | 0.5 | 1 |
Flushing/pallor | 0 | 0.5 | 1 |
Hypertension | 0 | Chronic: 1 | Paroxysmal: 2 |
Diabetes | 0 | 1 |
The scoring system assigns weighted values to 11 selected signs and symptoms (for details see ‘Materials and methods’ section). The maximum score sum value is 15. Values ≤2.5 and ≥3.0 define asymptomatic and symptomatic disease, respectively.
aMental impairments, for example, anxiety, changes in mood and perception, nervousness, lethargy.